Anhedonia as a potential transdiagnostic phenotype with immune-related changes in recent onset mental health disorders.

Anhedonia Depression Inflammation Prediction Psychosis Transdiagnostic

Journal

Biological psychiatry
ISSN: 1873-2402
Titre abrégé: Biol Psychiatry
Pays: United States
ID NLM: 0213264

Informations de publication

Date de publication:
30 May 2024
Historique:
received: 06 02 2024
revised: 18 04 2024
accepted: 17 05 2024
medline: 2 6 2024
pubmed: 2 6 2024
entrez: 1 6 2024
Statut: aheadofprint

Résumé

Chronic low-grade inflammation is observed across mental disorders and is associated with difficult-to-treat-symptoms of anhedonia and functional brain changes - reflecting a potential transdiagnostic dimension. Previous investigations have focused on distinct illness categories in those with enduring illness, with few exploring inflammatory changes. We sought to identify an inflammatory signal and associated brain function underlying anhedonia among young people with recent onset psychosis (ROP) and recent onset depression (ROD). Resting-state functional magnetic resonance imaging, inflammatory markers, and anhedonia symptoms were collected from N=108 (M age=26.2[SD 6.2]years; Female =50) participants with ROP (n=53) and ROD (n=55) from the EU-FP7-funded PRONIA study. Time-series were extracted using the Schaefer atlas, defining 100 cortical regions of interest. Using advanced multimodal machine learning, an inflammatory marker model and functional connectivity model were developed to classify an anhedonic group, compared to a normal hedonic group. A repeated nested cross-validation model using inflammatory markers classified normal hedonic and anhedonic ROP/ROD groups with a balanced accuracy (BAC) of 63.9%, and an area under the curve (AUC) of 0.61. The functional connectivity model produced a BAC of 55.2% and an AUC of 0.57. Anhedonic group assignment was driven by higher levels of Interleukin-6, S100B, and Interleukin-1 receptor antagonist, and lower levels of Interferon gamma, in addition to connectivity within the precuneus and posterior cingulate. We identified a potential transdiagnostic anhedonic subtype that was accounted for by an inflammatory profile and functional connectivity. Results have implications for anhedonia as an emerging transdiagnostic target across emerging mental disorders.

Sections du résumé

BACKGROUND BACKGROUND
Chronic low-grade inflammation is observed across mental disorders and is associated with difficult-to-treat-symptoms of anhedonia and functional brain changes - reflecting a potential transdiagnostic dimension. Previous investigations have focused on distinct illness categories in those with enduring illness, with few exploring inflammatory changes. We sought to identify an inflammatory signal and associated brain function underlying anhedonia among young people with recent onset psychosis (ROP) and recent onset depression (ROD).
METHOD METHODS
Resting-state functional magnetic resonance imaging, inflammatory markers, and anhedonia symptoms were collected from N=108 (M age=26.2[SD 6.2]years; Female =50) participants with ROP (n=53) and ROD (n=55) from the EU-FP7-funded PRONIA study. Time-series were extracted using the Schaefer atlas, defining 100 cortical regions of interest. Using advanced multimodal machine learning, an inflammatory marker model and functional connectivity model were developed to classify an anhedonic group, compared to a normal hedonic group.
RESULTS RESULTS
A repeated nested cross-validation model using inflammatory markers classified normal hedonic and anhedonic ROP/ROD groups with a balanced accuracy (BAC) of 63.9%, and an area under the curve (AUC) of 0.61. The functional connectivity model produced a BAC of 55.2% and an AUC of 0.57. Anhedonic group assignment was driven by higher levels of Interleukin-6, S100B, and Interleukin-1 receptor antagonist, and lower levels of Interferon gamma, in addition to connectivity within the precuneus and posterior cingulate.
CONCLUSION CONCLUSIONS
We identified a potential transdiagnostic anhedonic subtype that was accounted for by an inflammatory profile and functional connectivity. Results have implications for anhedonia as an emerging transdiagnostic target across emerging mental disorders.

Identifiants

pubmed: 38823495
pii: S0006-3223(24)01354-4
doi: 10.1016/j.biopsych.2024.05.019
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2024. Published by Elsevier Inc.

Auteurs

Paris Alexandros Lalousis (PA)

Department of Psychosis Studies, Institute of Psychiatry, Psychology & Neuroscience, King's College London; Department of Psychiatry and Psychotherapy, Ludwig Maxmilians University, Munich, Germany; Institute for Mental Health, University of Birmingham, Birmingham, United Kingdom; Centre for Human Brain Health, University of Birmingham, Birmingham, United Kingdom.

Aanya Malaviya (A)

Institute for Mental Health, University of Birmingham, Birmingham, United Kingdom; Centre for Human Brain Health, University of Birmingham, Birmingham, United Kingdom.

Ali Khatibi (A)

Institute for Mental Health, University of Birmingham, Birmingham, United Kingdom; Centre for Human Brain Health, University of Birmingham, Birmingham, United Kingdom.

Majid Saberi (M)

Institute for Mental Health, University of Birmingham, Birmingham, United Kingdom; Centre for Human Brain Health, University of Birmingham, Birmingham, United Kingdom.

Lana Kambeitz-Ilankovic (L)

Department of Psychiatry and Psychotherapy, Faculty of Medicine and University Hospital, University of Cologne, Cologne, Germany.

Shalaila S Haas (SS)

Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

Stephen J Wood (SJ)

Institute for Mental Health, University of Birmingham, Birmingham, United Kingdom; Centre for Human Brain Health, University of Birmingham, Birmingham, United Kingdom; Orygen, the National Centre of Excellence in Youth Mental Health; Melbourne, Australia.

Nicholas M Barnes (NM)

Institute for Clinical Sciences, University of Birmingham, United Kingdom.

Jack Rogers (J)

Institute for Mental Health, University of Birmingham, Birmingham, United Kingdom; Centre for Human Brain Health, University of Birmingham, Birmingham, United Kingdom.

Katharine Chisholm (K)

Institute for Mental Health, University of Birmingham, Birmingham, United Kingdom; Centre for Human Brain Health, University of Birmingham, Birmingham, United Kingdom.

Alessandro Bertolino (A)

Department of Basic Medical Sciences, Neuroscience and Sense Organs, University of Bari Aldo Moro, Bari, Italy.

Stefan Borgwardt (S)

Department of Psychiatry, University of Basel, Basel, Switzerland.

Paolo Brambilla (P)

Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy.

Joseph Kambeitz (J)

Department of Psychiatry and Psychotherapy, Faculty of Medicine and University Hospital, University of Cologne, Cologne, Germany.

Rebekka Lencer (R)

Department of Psychiatry and Psychotherapy, University of Lübeck, Lübeck, Germany; Institute for Translational Psychiatry, University of Münster, Münster, Germany.

Christos Pantelis (C)

Melbourne Neuropsychiatry Centre, University of Melbourne, Melbourne, Australia.

Stephan Ruhrmann (S)

Department of Psychiatry and Psychotherapy, Faculty of Medicine and University Hospital, University of Cologne, Cologne, Germany.

Raimo K R Salokangas (RKR)

Department of Psychiatry, University of Turku, Turku, Finland.

Frauke Schultze-Lutter (F)

Department of Psychiatry and Psychotherapy, University of Düsseldorf, Düsseldorf, Germany; Department of Psychology, Faculty of Psychology, Airlangga University, Surabaya, Indonesia.

Andre Schmidt (A)

Department of Psychiatry, University of Basel, Basel, Switzerland.

Eva Meisenzahl (E)

Department of Psychiatry and Psychotherapy, University of Düsseldorf, Düsseldorf, Germany.

Dominic Dwyer (D)

Orygen, the National Centre of Excellence in Youth Mental Health; Melbourne, Australia; Centre for Youth Mental Health, The University of Melbourne, Parkville, Australia.

Nikolaos Koutsouleris (N)

Department of Psychosis Studies, Institute of Psychiatry, Psychology & Neuroscience, King's College London; Department of Psychiatry and Psychotherapy, Ludwig Maxmilians University, Munich, Germany.

Rachel Upthegrove (R)

Institute for Mental Health, University of Birmingham, Birmingham, United Kingdom; Centre for Human Brain Health, University of Birmingham, Birmingham, United Kingdom; Birmingham Early Interventions Service, Birmingham Women's and Children's NHS Foundation Trust. Electronic address: r.upthegrove@bham.ac.uk.

Siân Lowri Griffiths (SL)

Institute for Mental Health, University of Birmingham, Birmingham, United Kingdom.

Classifications MeSH